Sanofi avoids fine as EU accepts offer to stop disparaging rival vaccine
17 Articles
17 Articles
The EU had opened an investigation at the end of June for a possible obstacle to competition. The Commission suspected Sanofi of having abused its dominant position by carrying out from 2024 to the autumn of 2025 a campaign of denigration against a vaccine by the Australian company CSL Seqirus, the Fluad, competitor of its own product, Efluelda. Brussels finally accepted the corrective measures promised by Sanofi. To address these concerns, the …
Sanofi avoids fine as EU accepts offer to stop disparaging rival ...
According to the European Commission, the French pharmaceutical company has unfairly advertised its flu vaccine. Sanofi is fined with commitments.
volksfreund.de
According to the European Commission, the French pharmaceutical company has unfairly advertised its flu vaccine. Sanofi is fined with commitments.
The French pharmaceutical multinational had initiated communication actions of disinformation and discredit against another competitor to "occupy a dominant position in the market" of high-dose influenza vaccines Covid pharmaceuticals reinvent themselves to survive: new vaccines and anti-obesity drugs The European Commission has forced the French pharmaceutical company Sanofi to end a misleading communication campaign aimed at health professiona…
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
